Adamas Pharmaceuticals Inc (ADMS) Return on Investment ROI from the third quarter of 2021 to third quarter of 2020 and for the year 2021, average high and low, overall ranking from Sep 30 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Adamas Pharmaceuticals Inc  (NASDAQ: ADMS)


Adamas Pharmaceuticals Inc's ROI from its third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Adamas Pharmaceuticals Inc's ROI in the third quarter of 2021?
Adamas Pharmaceuticals Inc recorded a cumulative net loss of $-63 million during 12 months ending in the third quarter of 2021, resulting in a negative return on investment (ROI) of -55.6%.

Within the Healthcare sector 675 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2021 from 0 to 4334.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Investment Change TTM 2.87 % -12.08 % -25.32 % -37.41 % -37.99 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 115 123 134 79 94
Return On Investment (TTM) -55.6 % -51.21 % -51.81 % -58.83 % -56.74 %
ADMS's Overall Ranking # 4334 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 4.8 % 4.56 % 5.48 % -11 % -10.44 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -63 -55 -53 -57 -62

ADMS Company Profile >> Back to ADMS Roi Comparisons >> See Annual ADMS Return On Investment



Return On Investment ADMS's Ranking
Within: No.
Industry # 305
Sector # 676
Overall # 4334

Return On Investment Statistics
High Average Low
7.17 %
-46.37 %
-65.02 %
(Dec 31 2014)   (Dec 31 2017)







Financial Statements
Adamas Pharmaceuticals Inc's III. Quarter Investments $ 115 Millions ADMS's Balance sheet
Adamas Pharmaceuticals Inc's III. Quarter Income $ -20 Millions Quarterly ADMS's Income Statement
ADMS's Income by Division See ADMS's Income by Division


ADMS Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 79 127 211 170 133
Y / Y Investment Growth -37.99 % -39.71 % 24.16 % 27.75 % 13.51 %
Net Income in Millions -57 -105 -131 -89 -60
Y / Y Net Income Growth - - - - -
Annual Return On Investment -72.93 % -82.86 % -62.22 % -52.77 % -45.25 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ADMS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ADMS's Competitors
Subscribers only: Roi for Adamas Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for ADMS's Customers

Other Ratios
ADMS's Roa ADMS's Inventory Turnover Ratio ADMS's Growth Rates ADMS's Dividend Statistics
ADMS's Profitability Ratios ADMS's Asset Turnover Ratio ADMS's Dividend Growth
ADMS's Roe ADMS's Valuation Ratios ADMS's Financial Strength Ratios ADMS's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2021, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.